SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml
Product details
Registration number: SIN11733P
Classification: Prescription Only
Active ingredients: CEFACLOR
Strength: 125 mg/5 ml
Dosage form: GRANULE, FOR SUSPENSION
Route: ORAL
Registrant: APEX PHARMA MARKETING PTE. LTD.
ATC code: J01DC04
HSA approval date: 27 November 2001
Manufacturer(s): XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Manufacturing country/countries: MALAYSIA
What are the HSA registration number and classification for SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN11733P
Classification: Prescription Only
What active ingredients and strength are recorded for SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: CEFACLOR
Strength: 125 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: GRANULE, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: APEX PHARMA MARKETING PTE. LTD.
Which manufacturers and countries are listed for SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Manufacturing country/countries: MALAYSIA
Where can I look up SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN11733P or the exact product name SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN11733P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)